The Glucagon-Like Peptide-1 Receptor Agonist, Liraglutide, Attenuates the Progression of Overt Diabetic Nephropathy in Type 2 Diabetic Patients
-
Published:2013
Issue:1
Volume:231
Page:57-61
-
ISSN:0040-8727
-
Container-title:The Tohoku Journal of Experimental Medicine
-
language:en
-
Short-container-title:Tohoku J. Exp. Med.
Author:
Imamura Shigeki1, Hirai Keiji1, Hirai Aizan1
Affiliation:
1. Department of Internal Medicine, Chiba Prefectural Togane Hospital
Publisher
Tohoku University Medical Press
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference26 articles.
1. Björck, S., Mulec, H., Johnsen, S.A., Nordén, G. & Aurell, M. (1992) Renal protective effect of enalapril in diabetic nephropathy. BMJ, 304, 339-343. 2. Breyer, J.A., Bain, R., Evans, J.K., Nahman, N.S. Jr., Lewis, E.J., Cooper, M., McGill, J. & Berl, T. (1996) Predictors of the progression of renal insufficiency in patients with insulin dependent diabetes and overt diabetic nephropathy. Kidney Int., 50, 1651-1658. 3. Bullock, B.P., Heller, R.S. & Habener, J.F. (1996) Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology, 137, 2968-2978. 4. Elbrønd, B., Jakobsen, G., Larsen, S., Agersø, H., Jensen, L.B., Rolan, P., Sturis, J., Hatorp, V. & Zdravkovic, M. (2002) Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjects. Diabetes Care, 25, 1398-1404. 5. Elving, L.D., Wetzels, J.F.M., van, Lier, H.J.J., de Nobel, E. & Berden, J.H.M. (1994) Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study. Diabetologia, 37, 604-609.
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|